KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to -$9.0 million.

  • Evolent Health's Other Working Capital Changes fell 49263.64% to -$9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.8 million, marking a year-over-year increase of 2550.25%. This contributed to the annual value of -$15.0 million for FY2024, which is 253.69% up from last year.
  • According to the latest figures from Q3 2025, Evolent Health's Other Working Capital Changes is -$9.0 million, which was down 49263.64% from -$28.7 million recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Other Working Capital Changes registered a high of $13.8 million during Q1 2023, and its lowest value of -$31.8 million during Q4 2023.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$1.9 million (2021), whereas its average is -$3.9 million.
  • As far as peak fluctuations go, Evolent Health's Other Working Capital Changes skyrocketed by 25729.17% in 2021, and later plummeted by 169779.29% in 2023.
  • Evolent Health's Other Working Capital Changes (Quarter) stood at -$1.9 million in 2021, then rose by 8.59% to -$1.8 million in 2022, then crashed by 1697.79% to -$31.8 million in 2023, then surged by 91.27% to -$2.8 million in 2024, then tumbled by 224.95% to -$9.0 million in 2025.
  • Its last three reported values are -$9.0 million in Q3 2025, -$28.7 million for Q2 2025, and $7.7 million during Q1 2025.